Cladribine tablets for relapsing-remitting multiple sclerosis: Efficacy across patient subgroups from the phase III CLARITY study.
暂无分享,去创建一个
P. Vermersch | G. Comi | G. Giovannoni | P. Rieckmann | S. Cook | P. Soelberg Sørensen | K. Rammohan | A. Hamlett | N. Kurukulasuriya